Radiology, Vol 201, 167-172, Copyright © 1996 by Radiological Society of North America

ARTICLES

Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents

J Lammer, KA Hausegger, F Fluckiger, FW Winkelbauer, R Wildling, GE Klein, SA Thurnher and L Havelec
Department of Angiography and Interventional Radiology, University of Vienna, Austria.

PURPOSE: To compare the clinical efficacy and treatment costs of plastic versus metal biliary stents. MATERIALS AND METHODS: In a randomized trial, 101 patients with malignant common bile duct obstruction underwent transhepatic stent implantation and were followed up until death. Patients were stratified into risk and nonrisk groups. Forty-nine patients received 12-F plastic stents, and 52 received expandable metal stents. Plastic endoprostheses were placed in a two- step procedure; metal stent, in a single procedure. Kaplan-Meier analyses were used to compare patient survival and stent patency rates. RESULTS: The 30-day mortality rate was significantly lower for metal stents (five of 52 [10%]) than plastic stents (12 of 49 [24%]; P = .05). The obstruction rate was 19% (10 of 52; median patency, 272 days) for metal stents and 27% for plastic stents (13 of 49; median patency, 96 days; P < .01). Median time until death or obstruction was longer for metal stents (122 vs 81 days; P < .01). Placement of metal stents was associated with shorter hospital stay (10 vs 21 days; P < .01) and lower cost ($7,542 vs $12,129; P < .01). CONCLUSION: Use of self- expanding metal stents appears to show substantial benefits for patients and to be cost-effective.

This article has been cited by other articles:

				S A Khan, A Miras, M Pelling, and S D Taylor-Robinson Cholangiocarcinoma and its management Gut, December 1, 2007; 56(12): 1755 - 1756. [Full Text] [PDF]

				C. S. Ho and M. D. Voss Self-Expandable Metallic Biliary Stents with Permanent Access Am. J. Roentgenol., February 1, 2005; 184(2): 410 - 414. [Abstract] [Full Text] [PDF]

				H Isayama, Y Komatsu, T Tsujino, N Sasahira, K Hirano, N Toda, Y Nakai, N Yamamoto, M Tada, H Yoshida, et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction Gut, May 1, 2004; 53(5): 729 - 734. [Abstract] [Full Text] [PDF]

				S A Khan, B R Davidson, R Goldin, S P Pereira, W M C Rosenberg, S D Taylor-Robinson, A V Thillainayagam, H C Thomas, M R Thursz, and H Wasan Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut, November 1, 2002; 51(90006): vi1 - 9. [Full Text] [PDF]

				H.-J. Wagner With or Against the Bile Flow? Radiology, October 1, 2002; 225(1): 7 - 9. [Full Text] [PDF]

				M. Schoder, P. Rossi, R. Uflacker, M. Bezzi, A. Stadler, M. A. Funovics, M. Cejna, and J. Lammer Malignant Biliary Obstruction: Treatment with ePTFE-FEP- covered Endoprostheses—Initial Technical and Clinical Experiences in a Multicenter Trial Radiology, October 1, 2002; 225(1): 35 - 42. [Abstract] [Full Text] [PDF]

				T. H. Baron Expandable Metal Stents for the Treatment of Cancerous Obstruction of the Gastrointestinal Tract N. Engl. J. Med., May 31, 2001; 344(22): 1681 - 1687. [Full Text] [PDF]

				M A NARAIN and R COCKEL How should endoscopic accessories be selected: trial or error? Gut, March 1, 2000; 46(3): 305 - 306. [Full Text] [PDF]